Company / Operating Margin
NeoGenomics Laboratories, Inc. Operating Margin History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
4.7%
FY2017
5-year range
-
FY2016-FY2017
Trend
+435.2%
vs FY2016
Sector context
#78 of 148
Health Care
What the data says
At 4.7%, NeoGenomics Laboratories, Inc.'s operating margin ranks #78 of 148 in the Health Care sector.
Based on SEC 10-K filings.
4.7% in FY2017.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#78 of 148 in Health CareTop 53% of 148This company 4.7% Sector average -284.8%
▼
+101.7% above sector average
Key checks
Key Insights
- In FY2017, operating margin increased 435.2% year-over-year.
- Currently 289.5pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | 4.7% | +435.2% |
| FY2016 | 0.9% | +100.8% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026